Copyright
©The Author(s) 2022.
World J Clin Cases. Oct 6, 2022; 10(28): 10193-10200
Published online Oct 6, 2022. doi: 10.12998/wjcc.v10.i28.10193
Published online Oct 6, 2022. doi: 10.12998/wjcc.v10.i28.10193
Figure 2 Molecular in situ hybridization demonstrated positivity for EBER.
A: Tumor cells are large, nucleus pleomorphic or elongated, deeply stained, diffuse, and patchy (hematoxylin-eosin staining, × 400); B: EBER positivity (in situ hybridization, × 400); C: CD3 positivity (Envision two-step immunohistochemical staining, × 400); D: CD56-positivity (Envision two-step immunohistochemical staining, × 400); E: Granzyme B positivity (Envision two-step immunohistochemical staining, × 400); F: Ki-67 positive expression rate of 80%.
- Citation: Li LJ, Zhang JY. Treatment of refractory/relapsed extranodal NK/T cell lymphoma with decitabine plus anti-PD-1: A case report. World J Clin Cases 2022; 10(28): 10193-10200
- URL: https://www.wjgnet.com/2307-8960/full/v10/i28/10193.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i28.10193